Cargando…

Single-cell sequencing technology applied to epigenetics for the study of tumor heterogeneity

BACKGROUND: Previous studies have traditionally attributed the initiation of cancer cells to genetic mutations, considering them as the fundamental drivers of carcinogenesis. However, recent research has shed light on the crucial role of epigenomic alterations in various cell types present within th...

Descripción completa

Detalles Bibliográficos
Autores principales: Hu, Yuhua, Shen, Feng, Yang, Xi, Han, Tingting, Long, Zhuowen, Wen, Jiale, Huang, Junxing, Shen, Jiangfeng, Guo, Qing
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10568863/
https://www.ncbi.nlm.nih.gov/pubmed/37821906
http://dx.doi.org/10.1186/s13148-023-01574-x
_version_ 1785119442834817024
author Hu, Yuhua
Shen, Feng
Yang, Xi
Han, Tingting
Long, Zhuowen
Wen, Jiale
Huang, Junxing
Shen, Jiangfeng
Guo, Qing
author_facet Hu, Yuhua
Shen, Feng
Yang, Xi
Han, Tingting
Long, Zhuowen
Wen, Jiale
Huang, Junxing
Shen, Jiangfeng
Guo, Qing
author_sort Hu, Yuhua
collection PubMed
description BACKGROUND: Previous studies have traditionally attributed the initiation of cancer cells to genetic mutations, considering them as the fundamental drivers of carcinogenesis. However, recent research has shed light on the crucial role of epigenomic alterations in various cell types present within the tumor microenvironment, suggesting their potential contribution to tumor formation and progression. Despite these significant findings, the progress in understanding the epigenetic mechanisms regulating tumor heterogeneity has been impeded over the past few years due to the lack of appropriate technical tools and methodologies. RESULTS: The emergence of single-cell sequencing has enhanced our understanding of the epigenetic mechanisms governing tumor heterogeneity by revealing the distinct epigenetic layers of individual cells (chromatin accessibility, DNA/RNA methylation, histone modifications, nucleosome localization) and the diverse omics (transcriptomics, genomics, multi-omics) at the single-cell level. These technologies provide us with new insights into the molecular basis of intratumoral heterogeneity and help uncover key molecular events and driving mechanisms in tumor development. CONCLUSION: This paper provides a comprehensive review of the emerging analytical and experimental approaches of single-cell sequencing in various omics, focusing specifically on epigenomics. These approaches have the potential to capture and integrate multiple dimensions of individual cancer cells, thereby revealing tumor heterogeneity and epigenetic features. Additionally, this paper outlines the future trends of these technologies and their current technical limitations.
format Online
Article
Text
id pubmed-10568863
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-105688632023-10-13 Single-cell sequencing technology applied to epigenetics for the study of tumor heterogeneity Hu, Yuhua Shen, Feng Yang, Xi Han, Tingting Long, Zhuowen Wen, Jiale Huang, Junxing Shen, Jiangfeng Guo, Qing Clin Epigenetics Review BACKGROUND: Previous studies have traditionally attributed the initiation of cancer cells to genetic mutations, considering them as the fundamental drivers of carcinogenesis. However, recent research has shed light on the crucial role of epigenomic alterations in various cell types present within the tumor microenvironment, suggesting their potential contribution to tumor formation and progression. Despite these significant findings, the progress in understanding the epigenetic mechanisms regulating tumor heterogeneity has been impeded over the past few years due to the lack of appropriate technical tools and methodologies. RESULTS: The emergence of single-cell sequencing has enhanced our understanding of the epigenetic mechanisms governing tumor heterogeneity by revealing the distinct epigenetic layers of individual cells (chromatin accessibility, DNA/RNA methylation, histone modifications, nucleosome localization) and the diverse omics (transcriptomics, genomics, multi-omics) at the single-cell level. These technologies provide us with new insights into the molecular basis of intratumoral heterogeneity and help uncover key molecular events and driving mechanisms in tumor development. CONCLUSION: This paper provides a comprehensive review of the emerging analytical and experimental approaches of single-cell sequencing in various omics, focusing specifically on epigenomics. These approaches have the potential to capture and integrate multiple dimensions of individual cancer cells, thereby revealing tumor heterogeneity and epigenetic features. Additionally, this paper outlines the future trends of these technologies and their current technical limitations. BioMed Central 2023-10-11 /pmc/articles/PMC10568863/ /pubmed/37821906 http://dx.doi.org/10.1186/s13148-023-01574-x Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Review
Hu, Yuhua
Shen, Feng
Yang, Xi
Han, Tingting
Long, Zhuowen
Wen, Jiale
Huang, Junxing
Shen, Jiangfeng
Guo, Qing
Single-cell sequencing technology applied to epigenetics for the study of tumor heterogeneity
title Single-cell sequencing technology applied to epigenetics for the study of tumor heterogeneity
title_full Single-cell sequencing technology applied to epigenetics for the study of tumor heterogeneity
title_fullStr Single-cell sequencing technology applied to epigenetics for the study of tumor heterogeneity
title_full_unstemmed Single-cell sequencing technology applied to epigenetics for the study of tumor heterogeneity
title_short Single-cell sequencing technology applied to epigenetics for the study of tumor heterogeneity
title_sort single-cell sequencing technology applied to epigenetics for the study of tumor heterogeneity
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10568863/
https://www.ncbi.nlm.nih.gov/pubmed/37821906
http://dx.doi.org/10.1186/s13148-023-01574-x
work_keys_str_mv AT huyuhua singlecellsequencingtechnologyappliedtoepigeneticsforthestudyoftumorheterogeneity
AT shenfeng singlecellsequencingtechnologyappliedtoepigeneticsforthestudyoftumorheterogeneity
AT yangxi singlecellsequencingtechnologyappliedtoepigeneticsforthestudyoftumorheterogeneity
AT hantingting singlecellsequencingtechnologyappliedtoepigeneticsforthestudyoftumorheterogeneity
AT longzhuowen singlecellsequencingtechnologyappliedtoepigeneticsforthestudyoftumorheterogeneity
AT wenjiale singlecellsequencingtechnologyappliedtoepigeneticsforthestudyoftumorheterogeneity
AT huangjunxing singlecellsequencingtechnologyappliedtoepigeneticsforthestudyoftumorheterogeneity
AT shenjiangfeng singlecellsequencingtechnologyappliedtoepigeneticsforthestudyoftumorheterogeneity
AT guoqing singlecellsequencingtechnologyappliedtoepigeneticsforthestudyoftumorheterogeneity